|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
813182298 |
| 003 |
DE-627 |
| 005 |
20230427061034.0 |
| 007 |
tu |
| 008 |
141230s2014 gw ||||| 00| ||ger c |
| 035 |
|
|
|a (DE-627)813182298
|
| 035 |
|
|
|a (DE-599)GBV813182298
|
| 035 |
|
|
|a (OCoLC)902880545
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a ger
|
| 044 |
|
|
|c XA-DE
|c XD-US
|
| 082 |
0 |
4 |
|a 610
|q DNB
|
| 084 |
|
|
|a 44.87
|2 bkl
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 245 |
1 |
0 |
|a Vedolizumab
|b ein neuer darmselektiver Integrin-Antagonist
|c [Hrsg.: Axel Dignaß]
|
| 264 |
|
1 |
|a Stuttgart [u.a.]
|b Thieme
|c 2014
|
| 300 |
|
|
|a 12 S.
|b graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Thieme drug report
|v 8.2014,15
|
| 500 |
|
|
|a Literaturverz. S. 11
|
| 700 |
1 |
|
|a Dignaß, Axel Uwe
|d 1962-
|0 (DE-588)128843446
|0 (DE-627)382393945
|0 (DE-576)297359363
|4 oth
|
| 830 |
|
0 |
|a Thieme drug report
|v 8.2014,15
|9 2014000815
|w (DE-627)547222505
|w (DE-576)275732320
|w (DE-600)2393126-7
|x 1865-2875
|7 ns
|
| 912 |
|
|
|a GBV_ILN_74
|
| 912 |
|
|
|a ISIL_DE-354
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_287
|
| 912 |
|
|
|a ISIL_DE-H20
|
| 936 |
b |
k |
|a 44.87
|j Gastroenterologie
|0 (DE-627)106409999
|
| 936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 74
|1 01
|x 0354
|b 1518130488
|c 00
|f Magazin
|d Z 5038-8,15
|e u
|j --%%--
|y zb
|z 16-01-15
|
| 980 |
|
|
|2 287
|1 01
|x 3287
|b 1515502996
|c 00
|f Z4
|d o. Sgn.
|e f
|j --%%--
|k Angebunden an: Zeitschrift für Gastroenterologie, 52.2014
|y z
|z 30-12-14
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 00
|a Antibodies, Monoclonal, Humanized
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 01
|a Gastroenteritis-drug therapy
|
| 984 |
|
|
|2 74
|1 01
|x 0354
|a 354$1314524X
|
| 985 |
|
|
|2 74
|1 01
|x 0354
|a Z 5038-8,15
|
